Summit-based Seqirus is ramping up its fight against influenza with the completion of a $156 million expansion of its manufacturing facility in North Carolina. The influenza-focused vaccine company ...

With pressure piling on for CSL, the Australian vaccine and plasma specialist has elected to part ways with its CEO on the ...

For many businesses, "company culture" is today's trendy phrase, with little substance to back it up. At CSL Seqirus, however, a patient-focused company culture has become a guiding force from the CEO ...

CSL Seqirus, one of the world’s top flu vaccine companies, scored a $30.1 million deal from the Biomedical Advanced Research and Development Authority (BARDA) to deliver an avian flu vaccine candidate ...

RESEARCH TRIANGLE PARK – With most of the world currently focused on the rapid spread of the Delta variant of COVID-19, we shouldn’t forget that flu season also is just around the corner. That fact ...

HOLLY SPRINGS, N.C. ‒ A quiet effort to prevent the next global pandemic began rolling off an assembly line this summer behind the gates of an office complex in suburban Raleigh. In this sprawling ...

The Food & Drug Administration approved a multi-dose vial presentation of Audenz, a vaccine made by Summit-based Seqirus for individuals six months and older against bird flu, also known as influenza ...

(RTTNews) - Seqirus, an influenza prevention provider and an arm of CSL Limited (CSL.AX), on Monday said the Biomedical Advanced Research and Development Authority or BARDA, has chosen the company to ...

The plans were announced Thursday morning as state officials approved a jobs grant worth up to $6.5 million. State and local officials are poised to announce a major economic development deal -- one ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved AFLURIA QUADRIVALENT (Influenza Vaccine) for use in people five years of age ...